Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024

Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024

Antiviral therapy is underutilized for outpatients at increased risk for severe COVID-19 or influenza. Results from this survey offer insights into treatment barriers from the infectious disease specialist perspective. Further education is needed about the benefits of early antiviral therapy.

Saved in:
Bibliographic Details
Published in:Open forum infectious diseases
Main Authors: Singleton, Jordan B, Wang, Dennis, Louis, Souci, Smith, Dallas J, Lambrou, Anastasia S, Beekmann, Susan E, Midgley, Claire M, Polgreen, Philip, Garg, Shikha, Ricaldi, Jessica N, Uyeki, Timothy M, Santibañez, Scott, Patel, Pragna
Format: Journal Article
Language:English
Published: 08-11-2024
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Antiviral therapy is underutilized for outpatients at increased risk for severe COVID-19 or influenza. Results from this survey offer insights into treatment barriers from the infectious disease specialist perspective. Further education is needed about the benefits of early antiviral therapy.
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofae666